L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
vMq20TM0AdRsFAhG
